The basis and advances in clinical application of boron neutron capture therapy.


Journal

Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111

Informations de publication

Date de publication:
07 Nov 2021
Historique:
received: 30 08 2021
accepted: 25 10 2021
entrez: 8 11 2021
pubmed: 9 11 2021
medline: 8 2 2022
Statut: epublish

Résumé

Boron neutron capture therapy (BNCT) was first proposed as early as 1936, and research on BNCT has progressed relatively slowly but steadily. BNCT is a potentially useful tool for cancer treatment that selectively damages cancer cells while sparing normal tissue. BNCT is based on the nuclear reaction that occurs when

Identifiants

pubmed: 34743756
doi: 10.1186/s13014-021-01939-7
pii: 10.1186/s13014-021-01939-7
pmc: PMC8573925
doi:

Substances chimiques

Boron Compounds 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

216

Informations de copyright

© 2021. The Author(s).

Références

Br J Radiol. 2008 Sep;81(969):749-52
pubmed: 18541628
J Neurooncol. 2009 Jan;91(2):199-206
pubmed: 18813875
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S37-42
pubmed: 19409799
J Radiat Res. 2020 Nov 16;61(6):945-951
pubmed: 32990318
J Neurooncol. 1997 May;33(1-2):59-70
pubmed: 9151224
Int J Clin Oncol. 2020 Jan;25(1):43-50
pubmed: 31168726
J Neurosurg. 2005 Dec;103(6):1000-9
pubmed: 16381186
J Nucl Med. 1998 Feb;39(2):325-33
pubmed: 9476945
J Neurosurg. 1952 Mar;9(2):200-9
pubmed: 14908655
ACS Appl Mater Interfaces. 2018 Dec 19;10(50):43387-43395
pubmed: 30451482
Eur J Cancer. 2002 Mar;38 Suppl 4:S31-4
pubmed: 11858961
J Radiat Res. 2016 Aug;57 Suppl 1:i83-i89
pubmed: 27021218
Acta Neurol Scand. 2010 Jul;122(1):58-62
pubmed: 19951268
Appl Radiat Isot. 2004 Nov;61(5):1039-43
pubmed: 15308189
Cancer Res. 1997 Mar 15;57(6):1129-36
pubmed: 9067283
J Neurooncol. 1997 May;33(1-2):141-52
pubmed: 9151231
Expert Rev Neurother. 2015 May;15(5):477-91
pubmed: 25936845
J Neurooncol. 2003 Mar-Apr;62(1-2):123-34
pubmed: 12749708
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):127-9
pubmed: 2928932
Sci Adv. 2020 Jan 22;6(4):eaaz1722
pubmed: 32010792
Colloids Surf B Biointerfaces. 2017 Nov 1;159:217-231
pubmed: 28797972
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S47-9
pubmed: 19395269
Neurosurgery. 1999 Jun;44(6):1182-92; discussion 1192-3
pubmed: 10371617
Prog Neurol Surg. 2018;32:48-56
pubmed: 29990973
J Neurooncol. 2003 Mar-Apr;62(1-2):87-99
pubmed: 12749705
Cancer. 1992 Dec 15;70(12):2995-3007
pubmed: 1451084
Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1081-6
pubmed: 8600091
J Med Chem. 1967 Jul;10(4):714-7
pubmed: 6037065
Bioconjug Chem. 2019 Nov 20;30(11):2870-2878
pubmed: 31593447
Int J Oral Maxillofac Surg. 2009 Mar;38(3):293-5
pubmed: 19179044
Biomaterials. 2012 May;33(13):3568-77
pubmed: 22326646
J Neurooncol. 2003 Mar-Apr;62(1-2):135-44
pubmed: 12749709
Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1061-6
pubmed: 8175390
Appl Radiat Isot. 2004 Nov;61(5):1101-5
pubmed: 15308199
Appl Radiat Isot. 2014 Jun;88:23-7
pubmed: 24369888
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e67-75
pubmed: 21300462
Cancer. 1955 May-Jun;8(3):601-15
pubmed: 14379150
J Control Release. 2014 Jun 10;183:77-86
pubmed: 24675377
Radiat Res. 1999 Jan;151(1):1-18
pubmed: 9973079
Head Neck. 2006 Sep;28(9):850-5
pubmed: 16721735
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):369-76
pubmed: 21236605
Cancer Commun (Lond). 2018 Jun 19;38(1):36
pubmed: 29914575
Oncol Rep. 2007 Oct;18(4):861-6
pubmed: 17786347
Chem Rev. 1998 Jun 18;98(4):1515-1562
pubmed: 11848941
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):251-4
pubmed: 2494743
Appl Radiat Isot. 2004 Nov;61(5):1069-73
pubmed: 15308194
Am J Roentgenol Radium Ther Nucl Med. 1954 Feb;71(2):279-93
pubmed: 13124616
Cancer Res. 1990 Jan 1;50(1):138-41
pubmed: 2293547
J Radiat Res. 2009 Jan;50(1):51-60
pubmed: 18957828
Radiother Oncol. 2011 Apr;99(1):98-9
pubmed: 21397966
J Neuropathol Exp Neurol. 1972 Apr;31(2):278-303
pubmed: 4337274

Auteurs

Huifang He (H)

Department of Radiotherapy, Peking University International Hospital, Beijing, China.

Jiyuan Li (J)

College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.

Ping Jiang (P)

Department of Radiotherapy, Peking University 3rd Hospital, Beijing, 100191, China.

Suqing Tian (S)

Department of Radiotherapy, Peking University 3rd Hospital, Beijing, 100191, China.

Hao Wang (H)

Department of Radiotherapy, Peking University 3rd Hospital, Beijing, 100191, China.

Ruitai Fan (R)

Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Junqi Liu (J)

Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Yuyan Yang (Y)

Department of Radiotherapy, Peking University International Hospital, Beijing, China.

Zhibo Liu (Z)

College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China. zbliu@pku.edu.cn.

Junjie Wang (J)

Department of Radiotherapy, Peking University 3rd Hospital, Beijing, 100191, China. junjiewang_edu@sina.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH